Prostate health index (PHI) and prostate-specific antigen (PSA) predictive models for prostate cancer in the Chinese population and the role of digital rectal examination-estimated prostate volume
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
http://link.springer.com/content/pdf/10.1007/s11255-016-1350-8.pdf
Reference21 articles.
1. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V et al (2014) Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 384(9959):2027–2035
2. Andriole GL, Crawford ED, Grubb RL 3rd, Ss Buys, Chia D, Church TR et al (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360(13):1310–1319
3. Kranse R, Roobol MJ, Schröder FH (2008) A graphical device to represent the outcomes of a logistic regression analysis, an illustration of its possible use in prostate cancer screening and prostate cancer treatment counseling. Prostate 68:1674–1680
4. Roobol MJ, van Vugt HA, Loeb S, Zhu X, Bul M, Bangma CH et al (2012) Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators. Eur Urol 61:577–583
5. Ankerst DP, Hoefler J, Bock S, Goodman PJ, Vickers A, Hernandez J et al (2014) The Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- versus high-grade prostate cancer. Urology 83(6):1362–1367
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A 2‐year prospective evaluation of the Prostate Health Index in guiding biopsy decisions in a large cohort;BJU International;2024-07-04
2. Based on PI‐RADS v2.1 combining PHI and ADC values to guide prostate biopsy in patients with PSA 4−20 ng/mL;The Prostate;2023-12-20
3. The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men;Asian Journal of Andrology;2023
4. Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis;European Urology Open Science;2022-12
5. Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and Diagnosis;Value in Health;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3